[Stereotactic radiotherapy for operable stage I non-small cell lung cancer].
Fiche publication
Date publication
août 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MARTIN Etienne
Tous les auteurs :
Martin É, Nicolet C, Boisselier P, Khalifa J, Thureau S
Lien Pubmed
Résumé
Standard treatment stage of non-small cell lung cancer is currently surgery. For inoperable patients, stereotactic body radiotherapy is the reference treatment. This non-invasive technique has developed considerably and its excellent results in terms of carcinological control and tolerance raise the question of its indication for operable patients, especially for old patients and/or with comorbidities. This article reviews the available data in the literature of the place of stereotactic body radiotherapy for medically operable patients with stage I non-small cell lung cancer.
Mots clés
Cancer bronchique non à petites cellules, Early stage, NSCLC, Non-small cell lung cancer, Radiation therapy, Radiothérapie stéréotaxique, Stade précoce, Stereotactic body radiotherapy
Référence
Cancer Radiother. 2023 08 8;: